full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong><br />
Vol. 5 (3) 1325-1337 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)<br />
Sequential Optimization <strong>of</strong> Production <strong>of</strong> Cephamycin C Using<br />
Nocardia lactamdurans: Effect <strong>of</strong> Nutritional Supplements,<br />
Metabolic Precursors <strong>and</strong> Inducers<br />
Lalit D. Kagliwal*, Shrikant A. Survase <strong>and</strong> Rekha S. Singhal<br />
Food Engineering <strong>and</strong> Technology Department, Institute <strong>of</strong> Chemical Technology<br />
Matunga, Mumbai 400 019, India<br />
*For Correspondence - lalitkagliwal@gmail.com<br />
1325<br />
Abstract<br />
In this study, Nocardia lactamdurans<br />
NRRL 3802 was optimized for the first time for<br />
production <strong>of</strong> cephamycin C by using submerged<br />
fermentation. The effects <strong>of</strong> various carbon<br />
source, nitrogen source, inoculum size, initial pH<br />
<strong>of</strong> culture medium, minerals <strong>and</strong> amino acids<br />
were investigated for the maximum production<br />
<strong>of</strong> cephamycin C by N. lactamdurans NRRL<br />
3802 in submerged fermentation. Subsequently,<br />
selected fermentation parameters were further<br />
optimized by Taguchi orthogonal array method<br />
<strong>and</strong> response surface methodology (RSM).<br />
Glycerol <strong>and</strong> yeast extract as carbon <strong>and</strong> nitrogen<br />
sources with initial pH <strong>of</strong> culture medium <strong>of</strong> 5.5<br />
<strong>and</strong> inoculum size <strong>of</strong> 10 9 CFU/ml at 28 ± 2 °C<br />
after 3 days gave maximum production <strong>of</strong><br />
3042.19 ± 62.36 mg/l <strong>of</strong> cephamycin C as<br />
compared to 243.03 ± 9.43 mg/l before<br />
optimization. Incorporation <strong>of</strong> 1,3-<br />
diaminopropane at 1.2 % v/v in RSM optimized<br />
medium further increased the yield to 3973.20 ±<br />
57.96 mg/l.<br />
Keywords: Cephamycin C, Nocardia<br />
lactamdurans, Inducer, Taguchi, RSM<br />
Introduction<br />
Since the discovery <strong>of</strong> penicillin, a number<br />
<strong>of</strong> microbial species producing a variety <strong>of</strong><br />
related antibiotic products have been isolated.<br />
In all, over 1,000 naturally occurring or<br />
chemically modified antibiotic products have<br />
been reported, <strong>of</strong> which over 100 are<br />
commercially produced. One important class <strong>of</strong><br />
microbially produced compounds, the<br />
cephamycins, was separately isolated in the early<br />
1970s by Merck <strong>and</strong> Co., Inc., Germany <strong>and</strong> by<br />
Eli Lilly <strong>and</strong> Co., IN, USA. Cephamycin C is<br />
one <strong>of</strong> the extracellularly produced â-lactam<br />
antibiotics having hydrophilic properties. They<br />
are produced by actinomycetes such as Nocardia<br />
lactamdurans (1) <strong>and</strong> several species <strong>of</strong><br />
Streptomyces viz. Streptomyces cattleya <strong>and</strong><br />
Streptomyces clavuligerus (2). The increasing<br />
occurrence <strong>of</strong> bacterial resistance to â-lactam<br />
antibiotics is through synthesis <strong>of</strong> the enzyme â-<br />
lactamases that hydrolyze the â-lactam ring.<br />
Cephamycins are substituted with a methoxy<br />
group at the 7á-position <strong>of</strong> the cephalosporin<br />
nucleus, a modification that considerably reduces<br />
inactivation by â-lactamases. It is currently being<br />
used as an intermediate for semi-synthetic<br />
antibiotics such as cefoxitin, cefametazole <strong>and</strong><br />
cefotetan having better pharmacokinetic <strong>and</strong><br />
pharmacodynamic properties.<br />
Development <strong>of</strong> economical medium<br />
requires selection <strong>of</strong> carbon, nitrogen, inorganic<br />
salts, <strong>and</strong> trace element sources. The optimization<br />
<strong>of</strong> nutritional <strong>and</strong> environmental conditions plays<br />
an important role in developing bioprocesses <strong>and</strong><br />
improving their performance. Nutritional<br />
Sequential optimization <strong>of</strong> cephamycin C